Marrakech, March 1st. (Morocco News) –
Technology is playing an increasingly important role in all sectors and in all areas. Healthcare is positioned as one of the areas with the greatest potential to reap the benefits of digitalization. despite the fact that some issues, such as data privacy, still need to be seriously addressed. This was told by a group of experts during an event organized by Mapfre in conjunction with Accenture as part of the Mobile World Congress (MWC) in Barcelona.
During the conference, held in Barcelona’s iconic Mapfre tower, experts discussed the following topics. advances and trends that will shape the future of healthcare. Researchers, startups, investors and broadcasters discussed the importance of digitalization of the sector and its role in the new reality of treatment, diagnosis, prevention and patient experience.
“The digital health market is growing very fast,” said Nicolas Monsarrat, Head of Digital Health Europe at Accenture, during the conference’s opening keynote. More precisely, this growth will be 29.6% between 2019 and 2023, achieve configurationsby 2025 the market will be 504 billion dollars, according to a consulting firm.
Mr Monsarrat stressed the importance of putting the patient at the center of the equation, in which smart technology devices and the healthcare system will also play a role. Data and its analysis will also be the key to success. In this regard, he underscored Europe’s efforts to create an ecosystem that gives users confidence compared to collection of your data and privacy but which – at the same time – allows companies and administrations to use it to create a more efficient system and stimulate research in this area.
PERSONALIZED MEDICINE: THE FUTURE IS IN THE GENES
The event, which coincided with the celebration of World Rare Disease Day, was also attended by Luis Montoliu, biologist and CSIC and CIBER researcher on rare diseases at the National Center for Biotechnology (CNB), who emphasized the importance the possibilities arising from the use of “precision medicine”, the most personalized. “The most important thing is to diagnose people and then try to adapt treatments,” he said.
6.5% of the world’s population suffer from rare diseases. In Spain, the figure is 3 million people.. At this point, Montoliu explains that most diseases caused by genetic changes and so the first thing to do is find out what’s wrong. “We have impressive tools, but even then genetic diagnosis can take a long time,” he says.
That is why he reiterates the importance strong commitment to science and research: “Upfront investment is needed. Knowledge gives credit for many years to come.” In this regard, he notes that if there is anything special about the pandemic, it is the ability of the scientific community to adapt and collaborate.
Mr. Montoliu has worked in the field of genetics for 25 years and has seen how technology is changing the way people work. “In the late 1990s, we sequenced the genome for the first time. At that time It may take me two and a half years to inactivate the gene, which now takes several weeks. he points. There is no doubt that artificial intelligence, data exploitation and supercomputing will revolutionize the sector and this is just the tip of the iceberg.
“The BIGGEST PROBLEM IS THE LACK OF DATA.”
Finally, a symposium entitled “Accelerating Change” was organized with the participation of Pedro Diaz-Juste, Director of Digital Health at Mapfre, Mikel A. Bru Angelats, Vice President of Business Development at Made of Genes, and Luis Martin Ezama. , CEO of CancerAppy. A spokesman for the latter, dedicated to discovering the patterns of various types of cancer through calculations, opened the discussion with the question that most hinders research: “…the most important thing to do is to understand the causes of cancer.” he said.The big problem is the lack of data.”
” For us easier to get data from USA than local data. There is an incredible fear in Europe about how this data could be used, and it is important that radical changes take place. We must ensure that data is transferred to science in the same way that organs are transferred. The more data we have, the easier it will be to achieve precision medicine. This is the first step,” said Mr. Ezama.
For his part, the head of Made of Genes said that personalized medicine goes in two directions and therefore “you have to make the patient a partner.” In this sense, he undertakes Empower citizens to choose to share their data to improve their health and habits.. The same data can – at the same time – help to study diseases and treat them.
Finally, Ms. Diaz-Juste explained that the idea of putting the patient at the center of the strategy will be one of the keys to digital health. Here’s how Mapfre suggested his telemedicine and virtual care platform, Saviawhich was provided free of charge to all citizens during the pandemic. “At that time, 100% of medical services had to be digital, and people understood the value of this service,” says the company’s director of digital health, adding that for 60% of users, this was their first contact with telemedicine.
“We take customer experience seriously and manage data ambitiously, always with the informed consent of the client“, adds Mr. Diaz-Juste, who is pleased with the high recognition of the service: the satisfaction rate exceeds 95%. “Telemedicine is not suitable for all patients and not in all cases, but it will play an important role. We are reaching a certain level of maturity,” he said.